JenaValve Technology said today that it named former ReVision Optics prez & CEO John Kilcoyne as its new chief executive officer, effective immediately, replacing Dr. Victoria Carr-Brendell, who has taken up an executive leadership position with Sonova Holding AG (SIX:SOON). Prior to his time at ReVision Optics, Kilcoyne served as prez & CEO at Micrus Endovascular where he […]
Natus takes a hit on Q3 misses
Investors pushed share prices down today for Natus Medical (NSDQ:BABY) after the neonatal care company missed expectations with its third-quarter results. Pleasanton, Calif.-based Natus pared its losses by -34.5% to -$5.6 million, or -17¢ per share, on sales growth of 6.5% to $130.6 million for the three months ended Sept. 30, compared with Q3 2017. […]
Motus GI taps Moran as CEO | Personnel Moves – September 25, 2018
Motus GI said today that it named Timothy Moran as its new chief executive officer, effective October 1, replacing former CEO Mark Pomeranz who will assume the role of president and COO. Moran has previously served ConvaTec‘s (LON:CTEC) Americas president and helped lead the company through its initial public offering in 2016. Prior to ConvaTec, Moran spent […]
Natus Medical beats Q2 estimates, cuts full-year guidance
Shares in Natus Medical (NSDQ:BABY) rose today after the company topped expectations on Wall Street with its second-quarter financial results. The Pleasanton, Calif.-based company posted a net loss of -$2.6 million, or -8¢ per share, on sales of $130.7 million for the 3 months ended June 30, for sales growth of 7% compared with the same […]
Natus Medical lifts Kennedy to the corner office | Personnel Moves – July 17, 2018
Natus Medical (Nasdaq: BABY) said last week that its current CEO Jim Hawkins is retiring from their position, with current chief financial officer Jonathan Kennedy slated to take over as prez & chief exec. Kennedy has operated as CFO since April 2013, while the retiring Hawkins spent 14 years as the chief exec, the Pleasanton, Calif.-based company said. […]
Natus Medical faces proxy battle with Voce Capital
Natus Medical (Nasdaq: BABY) is facing a proxy battle with investment firm Voce Capital which is urging shareholders to oust chairman Robert Gunst. The Pleasanton, Calif.-based company referenced a recent report from Glass Lewis & Co. regarding its most recent annual meeting, which stated that Voce “has not presented a detailed operating plan for the company, nor […]
Nox Medical touts win in ongoing patent spat with Natus Medical
Nox Medical today touted a win in an ongoing patent spat with Natus Medical (Nasdaq: BABY) over patents related to biometric connectors. The Iceland-based company said that a jury in the US District Court for the District of Delaware upheld the validity of Nox’s patent for biometric connectors it uses on its disposable RIP belts. The jury also […]
Natus Medical Q1 results beat The Street despite swing to red ink
Shares in Natus Medical (Nasdaq: BABY) fell today after the newborn-focused medical device maker posted first quarter earnings that saw profits turn to losses, despite topping Wall Street expectations for sales and earnings per share. The Pleasanton, Calif.-based company posted losses of approximately $3.2 million, or 10¢ per share, on sales of $128.6 million for the three […]
Nox Medical claims win over Natus Medical in EU sensor patent spat
Nox Medical yesterday touted a win in a European patent spat with Natus Medical (Nasdaq: BABY) over patents related to biometric connectors. Iceland-based Nox Medical said that the European Patent Office determined that its European patent, related to its RIP Belts, were “valid as amended” in proceedings brought against it by Natus. The company went on […]
Cerner taps former head of Philips North America to take over corner officer | Personnel Moves January 11, 2018
Cerner Corp. (NSDQ:CERN) said yesterday that it named Brent Shafer to serve as chairman & CEO effective Feb. 1. Shafer previously served as CEO of Philips‘ (NYSE:PHG) North America business. Cerner’s co-founder Cliff Illig has been serving as interim CEO and chairman of the board since July last year. Illig said he plans to resume […]
Integra LifeSciences completes purchase of J&J’s Codman Neurosurgery
Integra LifeSciences (Nasdaq: IART) has completed its previously announced $1.045 billion purchase of Johnson & Johnson’s Codman Neurosurgery business, the companies announced today. “The addition of Codman Neurosurgery expands our global leadership position by creating one of the broadest medical device portfolios in the neurosurgery market,” Peter Arduini, Integra’s president and CEO, said in a […]
- 1
- 2
- 3
- …
- 5
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube